Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19743705 | 1.00 | CNR2 (0.81) | CNR2CNR1 | |
| SCHEMBL29848686 | 0.90 | CNR2 (1.00) | CNR2CNR1 | |
| SCHEMBL20952227 | 0.90 | CNR2 (1.00) | CNR2CNR1 | |
| SCHEMBL19743376 | 0.89 | CNR2 (0.81) | CNR2CNR1 | |
| SCHEMBL30298762 | 0.89 | CNR2 (0.81) | CNR2CNR1 | |
| SCHEMBL19743694 | 0.85 | CNR2 (0.76) | CNR2CNR1 | |
| SCHEMBL19743372 | 0.84 | CNR2 (1.00) | CNR2CNR1 | |
| SCHEMBL19743692 | 0.84 | CNR2 (0.77) | CNR2CNR1 | |
| SCHEMBL25437955 | 0.83 | CNR2 (0.75) | CNR2CNR1 | |
| SCHEMBL19744040 | 0.83 | CNR2 (0.73) | CNR2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115093418-A | [1,2,3] triazolo [4,5-d ] pyrimidine derivatives having affinity for cannabinoid type 2 receptors | 豪夫迈·罗氏有限公司 | 2022-09-23 | — | — | CN | claimed |
| CN-115073476-A | [1,2,3] triazolo [4,5-d ] pyrimidine derivatives having affinity for cannabinoid type 2 receptors | 豪夫迈·罗氏有限公司 | 2022-09-20 | — | — | CN | claimed |
| CN-115093418-A | [1,2,3] triazolo [4,5-d ] pyrimidine derivatives having affinity for cannabinoid type 2 receptors | 豪夫迈·罗氏有限公司 | 2022-09-23 | — | — | CN | disclosed |
| CN-115073476-A | [1,2,3] triazolo [4,5-d ] pyrimidine derivatives having affinity for cannabinoid type 2 receptors | 豪夫迈·罗氏有限公司 | 2022-09-20 | — | — | CN | disclosed |